1. [O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD. (1st July 2017) Authors: Kerchner, Geoffrey A.; Ayalon, Gai; Brunstein, Flavia; Chandra, Priya; Datwani, Akash; Fuji, Reina N.; Manser, Paul T.; Vaze, Anjali; Ward, Michael; Wildsmith, Kristin R.; Foo‐Atkins, Corinne Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P1–109]: MATHEMATICAL MODEL OF AMYLOID BETA (Aβ) DYNAMICS TO ASSESS TARGET ENGAGEMENT OF SOLUBLE Aβ OLIGOMERS BY CRENEZUMAB IN THE ALZHEIMER's DISEASE BRAIN. (1st July 2017) Authors: Ferl, Gregory Z.; Fuji, Reina N.; Atwal, Jasvinder; Ramanujan, Saroja; Quartino, Angelica Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. (22nd May 2018) Authors: Cummings, Jeffrey L.; Cohen, Sharon; van Dyck, Christopher H.; Brody, Mark; Curtis, Craig; Cho, William; Ward, Michael; Friesenhahn, Michel; Rabe, Christina; Brunstein, Flavia; Quartino, Angelica; Honigberg, Lee A.; Fuji, Reina N.; Clayton, David; Mortensen, Deborah; Ho, Carole; Paul, Robert Journal: Neurology Issue: Volume 90:Number 21(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Injectable Polymer‐Nanoparticle Hydrogel for the Sustained Intravitreal Delivery of Bimatoprost. Issue 2 (31st October 2022) Authors: Meany, Emily L.; Andaya, Roxanne; Tang, Shijia; Kasse, Catherine M.; Fuji, Reina N.; Grosskopf, Abigail K.; d'Aquino, Andrea L.; Bartoe, Joshua T.; Ybarra, Ryan; Shelton, Amy; Pederson, Zachary; Hu, Chloe; Leung, Dennis; Nagapudi, Karthik; Ubhayakar, Savita; Wright, Matthew; Yen, Chun‐Wan; Appel,... Journal: Advanced therapeutics Issue: Volume 6:Issue 2(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O1‐02‐04: BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER'S DISEASE (CREAD). (1st July 2006) Authors: Lin, Helen; Ostrowitzki, Susanne; Sink, Kaycee M.; Millar, Laurie; Warren, Francis; Smith, Jillian; Schneider, Andres; Fuji, Reina N.; Quartino, Angelica; Mackey, Howard; Rabbia, Michael A.; Yule, Susan; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1‐046: BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL‐TO‐MILD) ALZHEIMER'S DISEASE. (1st July 2019) Authors: Sink, Kaycee; Warren, Francis; Smith, Jillian; Schneider, Andres; Fuji, Reina N.; Quartino, Angelica; Mackey, Howard; Rabbia, Michael; Yule, Susan; Fontoura, Paulo; Doody, Rachelle; Ostrowitzki, Susanne Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates. (6th November 2022) Authors: Ramakrishnan, Vidya; Friedrich, Christina; Witt, Colleen; Sheehan, Robert; Pryor, Meghan; Atwal, Jasvinder K.; Wildsmith, Kristin; Kudrycki, Katherine; Lee, Seung‐Hye; Mazer, Norman; Hofmann, Carsten; Fuji, Reina N.; Jin, Jin Y.; Ramanujan, Saroja; Dolton, Michael; Quartino, Angelica Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 12:Number 1(2023) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Toxicologic Pathology Forum: A Roadmap for Building State-of-the-Art Digital Image Data Resources for Toxicologic Pathology in the Pharmaceutical Industry. (December 2022) Authors: Ge, Xing-Yue; Funk, Juergen; Albrecht, Tom; Birkhimer, Merima; Gilsdorf, Moritz; Hayes, Matthew; Hu, Fangyao; Maliver, Pierre; McCreary, Mark; Nguyen, Trung; Romero-Palomo, Fernando; Seger, Shanon; Fuji, Reina N.; Schumacher, Vanessa; Sullivan, Ruth Journal: Toxicologic pathology Issue: Volume 50:Number 8(2022) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid. Issue 4 (23rd February 2022) Authors: Sadekar, Shraddha S.; Bowen, Mayumi; Cai, Hao; Jamalian, Samira; Rafidi, Hanine; Shatz‐Binder, Whitney; Lafrance‐Vanasse, Julien; Chan, Pamela; Meilandt, William J.; Oldendorp, Amy; Sreedhara, Alavattam; Daugherty, Ann; Crowell, Susan; Wildsmith, Kristin R.; Atwal, Jasvinder; Fuji, Reina N.; Horv... Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 4(2022) Page Start: 826 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗